Literature DB >> 30532073

MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner.

Boya Liu1, Jingjie Yi2, Xin Yang1, Lu Liu1, Xinlin Lou1, Zeyuan Zhang1, Hao Qi1, Zhe Wang1, Junhua Zou1, Wei-Guo Zhu3, Wei Gu2, Jianyuan Luo4.   

Abstract

MDM2 (Murine double minute 2) acts as a key repressor for p53-mediated tumor-suppressor functions, which includes cellular senescence. We found that MDM2 can promote cellular senescence by modulating WRN stability. Werner syndrome (WS), caused by mutations of the WRN gene, is an autosomal recessive disease, which is characterized by premature aging. Loss of WRN function induces cellular senescence in human cancer cells. Here, we found that MDM2 acts as an E3 ligase for WRN protein. MDM2 interacts with WRN both in vivo and in vitro. MDM2 induces ubiquitination of WRN and dramatically downregulates the levels of WRN protein in human cells. During DNA damage response, WRN is translocated to the nucleoplasm to facilitate its DNA repair functions; however, it is degraded by the MDM2-mediated ubiquitination pathway. Moreover, the senescent phenotype induced by DNA damage reagents, such as Etoposide, is at least in part mediated by MDM2-dependent WRN degradation as it can be significantly attenuated by ectopic expression of WRN. These results show that MDM2 is critically involved in regulating WRN function via ubiquitin-dependent degradation and reveal an unexpected role of MDM2 in promoting cellular senescence through a p53-independent manner.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30532073     DOI: 10.1038/s41388-018-0605-5

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest.

Authors:  A Constantinou; M Tarsounas; J K Karow; R M Brosh; V A Bohr; I D Hickson; S C West
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

2.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 3.  The role of WRN in DNA repair is affected by post-translational modifications.

Authors:  Rika Kusumoto; Meltem Muftuoglu; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

4.  Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

Authors:  Zhao-Hui Wu; Yuling Shi; Randal S Tibbetts; Shigeki Miyamoto
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

5.  The premature ageing syndrome protein, WRN, is a 3'-->5' exonuclease.

Authors:  S Huang; B Li; M D Gray; J Oshima; I S Mian; J Campisi
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

Review 6.  Werner syndrome protein: biochemical properties and functional interactions.

Authors:  V A Bohr; M Cooper; D Orren; A Machwe; J Piotrowski; J Sommers; P Karmakar; R Brosh
Journal:  Exp Gerontol       Date:  2000-09       Impact factor: 4.032

Review 7.  The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.

Authors:  Meltem Muftuoglu; Junko Oshima; Cayetano von Kobbe; Wen-Hsing Cheng; Dru F Leistritz; Vilhelm A Bohr
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

8.  A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity.

Authors:  M Lebel; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.

Authors:  Koji Itahana; Hua Mao; Aiwen Jin; Yoko Itahana; Hilary V Clegg; Mikael S Lindström; Krishna P Bhat; Virginia L Godfrey; Gerard I Evan; Yanping Zhang
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

10.  Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2.

Authors:  Takumi Mikawa; Takeshi Maruyama; Koji Okamoto; Hitoshi Nakagama; Matilde E Lleonart; Takeshi Tsusaka; Kousuke Hori; Itsuo Murakami; Taisuke Izumi; Akifumi Takaori-Kondo; Masayuki Yokode; Gordon Peters; David Beach; Hiroshi Kondoh
Journal:  J Cell Biol       Date:  2014-02-24       Impact factor: 10.539

View more
  10 in total

1.  The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.

Authors:  Chunjie Meng; Jun Zhan; Delin Chen; Genze Shao; Hongquan Zhang; Wei Gu; Jianyuan Luo
Journal:  Oncogene       Date:  2021-02-02       Impact factor: 9.867

2.  The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1.

Authors:  Kifayat Ullah; Suping Chen; Jiaqi Lu; Xiaohui Wang; Qing Liu; Yang Zhang; Yaqiu Long; Zhanhong Hu; Guoqiang Xu
Journal:  J Biol Chem       Date:  2020-02-10       Impact factor: 5.157

3.  DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.

Authors:  Sigrid Uxa; Stephan H Bernhart; Christina F S Mages; Martin Fischer; Robin Kohler; Steve Hoffmann; Peter F Stadler; Kurt Engeland; Gerd A Müller
Journal:  Nucleic Acids Res       Date:  2019-09-26       Impact factor: 16.971

Review 4.  G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence.

Authors:  Paula Santos-Otte; Hanne Leysen; Jaana van Gastel; Jhana O Hendrickx; Bronwen Martin; Stuart Maudsley
Journal:  Comput Struct Biotechnol J       Date:  2019-08-23       Impact factor: 7.271

5.  Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2.

Authors:  Xiaohong Xiang; Yunong Fu; Kun Zhao; Runchen Miao; Xing Zhang; Xiaohua Ma; Chang Liu; Nu Zhang; Kai Qu
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

Review 6.  Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Authors:  Qianru Mei; Zhe Liu; He Zuo; Zhenhua Yang; Jing Qu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

7.  Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.

Authors:  Changfu Yao; Xiangrong Guan; Gianni Carraro; Tanyalak Parimon; Xue Liu; Guanling Huang; Apoorva Mulay; Harmik J Soukiasian; Gregory David; Stephen S Weigt; John A Belperio; Peter Chen; Dianhua Jiang; Paul W Noble; Barry R Stripp
Journal:  Am J Respir Crit Care Med       Date:  2021-03-15       Impact factor: 21.405

Review 8.  Ferroptosis, radiotherapy, and combination therapeutic strategies.

Authors:  Guang Lei; Chao Mao; Yuelong Yan; Li Zhuang; Boyi Gan
Journal:  Protein Cell       Date:  2021-04-23       Impact factor: 14.870

Review 9.  Cellular Senescence: Mechanisms and Therapeutic Potential.

Authors:  Zehuan Liao; Han Lin Yeo; Siaw Wen Wong; Yan Zhao
Journal:  Biomedicines       Date:  2021-11-25

10.  Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.

Authors:  Ding-Fang Zhang; Zhi-Chun Yang; Jian-Qiang Chen; Xiang-Xiang Jin; Yin-da Qiu; Xiao-Jing Chen; Hong-Yi Shi; Zhi-Guo Liu; Min-Shan Wang; Guang Liang; Xiao-Hui Zheng
Journal:  BMC Complement Med Ther       Date:  2021-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.